Form 4 holding
Chief Fin. and Bus. Officer
Lyell Immunopharma, Inc.
- Security class
- Option (right to buy)
- Shares / value
- 140,000
- Estimated value
- Report date
- 09 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount